Tablet fluvoxamine (200 mg/day) combined with placebo as control group for 8 weeks

2 trials

Sponsors

Tehran University of Medical Sciences

Conditions

Obsessive- Cumpulsive Disorder. Obsessive- Cumpulsive DisorderObsessive- Cumpulsive Disorder. Obsessive-compulsive disorder

Phase 3

Memantine in the treatment of obsessive-compulsive disorder

Active, not recruitingIRCT201106031556N22

Tehran University of Medical SciencesObsessive- Cumpulsive Disorder. Obsessive-compulsive disorder

Start: 2011-06-22Target: 40Updated: 2018-02-22

Granisetron in the treatment of obsessive-compulsive disorder

Active, not recruitingIRCT201202041556N32

Tehran University of Medical SciencesObsessive- Cumpulsive Disorder. Obsessive- Cumpulsive Disorder

Start: 2011-11-01Target: 40Updated: 2018-02-22

Related Papers

Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.

2012-10-0139 citations